NEMA ei June 2017 - 5

2017 ALZHEIMER'S
2017 ALZHEIMER'S
DISEASE FACTS AND
DISEASE FACTS AND
FIGURES
FIGURES
ALZHEIMER'S DISE ASE IS THE
ALZHEIMER'S DISE ASE IS THE

6TH LEADING CAUSE
6TH
CAUSE
OF DELEADING
ATH IN THE UNITED
ST ATES
OF DE ATH IN THE UNITED ST ATES

EVERY
EVERY

MORE TH AN
MORE
TH AN
5
MILLION
5
MILLION ARE
AMERICANS
AMERICANS
LIVING WITHARE
LIVING
WITH
ALZHEIMER'S
ALZHEIMER'S
BY 2050, THIS
BY
2050, THIS
NUMBER
COULD
NUMBER
COULD
RISE AS HIGH
AS
RISE
AS HIGH AS
16
MILLION
16 MILLION

MORE
THAN
MORE
THAN

66
66
SECONDS
SECONDS
someone in the

United States
someone
in the
develops
disease
Unitedthe
States
develops the disease

ELECTRIC NEWS

MITA Joins a Great IDEA to Fight Alzheimer's

J

une is Alzheimer's & Brain Awareness Month-a good time to remember the
5.5 million Americans living with Alzheimer's disease and the millions more
who are their caregivers.
Members of NEMA's Medical Imaging & Technology Alliance (MITA) are on
the front lines in the battle to end the disease. Member companies manufacture
the positron emission tomography (PET) scanners that assist in the diagnosis of
Alzheimer's and other brain disorders.
Three of MITA's PET Group members, Avid Radiopharmaceuticals, Piramal Imaging,
and GE Healthcare, are at the heart of a four-year research effort: the Imaging
Dementia-Evidence for Amyloid Scanning (IDEAS) Study. Amyloid imaging
uses a PET tracer to detect amyloid plaque buildup in the brain (a core feature of
Alzheimer's disease) that can help clinicians determine whether symptoms are caused
by Alzheimer's disease. The study will determine whether amyloid imaging improves
clinical decision-making and patient outcomes for Medicare beneficiaries.

15 MILLION AMERICANS
provide
unpaidAMERICANS
care for people with
15
MILLION

Until recently, amyloid plaques could be seen only during autopsies. While amyloid
PET imaging results do not establish a diagnosis, they may increase a physician's
confidence in determining the underlying cause of cognitive impairment and
appropriate therapies. Results may also guide patient management. Proof of amyloid
pathology is a requirement for inclusion in many Alzheimer's drug trials.

18.2
HOURS
of
careBILLION
valued at over
of
care valued
at over
$230
BILLION

Although amyloid PET scans have been FDA-approved for several years, only now are
they reimbursed by Medicare through the IDEAS Study. The Alzheimer's Association
led the initiative to develop a Centers for Medicare and Medicaid Services (CMS)
Coverage with Evidence Development program.

IN
2016
IN
2016

Alzheimer's
or other
dementias
provide
unpaid
care for
people with
Alzheimer's or other dementias
these caregivers provided
these
caregivers provided
an estimated
an
estimated
18.2
BILLION HOURS

$230 BILLION

In 2017, Alzheimer's and other
dementias
will cost the
nation
In
2017, Alzheimer's
and
other
$259 billionwill cost the nation
dementias
$259
billion
By 2050,
these costs could
rise2050,
as high
as costs could
By
these
rise as high as

$1.1 TRILLION
$1.1
TRILLION

35%%
35

of caregivers for people with
of
caregiversorfor
peopledementia
with
Alzheimer's
another
Alzheimer's
or another
dementia
report that their
health has
gotten worse
report
health has gotten
worse
due to that
caretheir
responsibilities,
compared
to
due to care
responsibilities,
compared
to
of
caregivers
for
older
people
%
caregivers
for older people
without
dementia
% of
without dementia

19
19

The study is conducted by the Alzheimer's Association and the American College
of Radiology. MITA and the three amyloid tracer companies serve on the study's
steering committee.
A total of 18,488 Medicare beneficiaries aged 65 and older who meet appropriate use
criteria are being enrolled over a period of 24 months at sites throughout the United
States. CMS approved the IDEAS study design in 2015. After the initial year of the
study, nearly half the expected participants are registered across 824 study sites. ei
Sue Bunning
Industry Director, Positron Emission Tomography, MITA

Learn more
1 IN 3
seniors
1
IN dies
3
with Alzheimer's or

seniors dies
another
dementia
with
Alzheimer's
or
another dementia

IT KILLS
IT
KILLS
MORE
THAN
MORE
THAN
breast cancer
andbreast
prostate
cancer
cancer
and prostate cancer

Since 2000, deaths
from
heart
disease
have
Since
2000,
deaths
decreased
by 14%
from
heart disease
have
decreased by 14%
while deaths from
Alzheimer's
disease
while deaths
fromhave
increased
by 89%have
Alzheimer's
disease
increased by 89%

Alzheimer's & Brain Awareness Month
www.alz.org/abam
Imaging Dementia-Evidence for Amyloid
Scanning (IDEAS) Study
www.ideas-study.org

COMBINED
COMBINED
www.nema.org

*

5
June 2017


http://www.alz.org/abam http://www.ideas-study.org http://www.nema.org

Table of Contents for the Digital Edition of NEMA ei June 2017

Comments from the Chairman
Views
Electric News
Looking Ahead for Building Systems
Adding Value through ESPCs
Energy Benchmarking Equals Energy Savings
Case Studies: NEMA Members Go Big on Innovation
Shining a Light on PV Wire
Advocacy
Code & Standards
International
Business Analytics
Spotlight
NEMA ei June 2017 - Cover1
NEMA ei June 2017 - Cover2
NEMA ei June 2017 - 1
NEMA ei June 2017 - 2
NEMA ei June 2017 - Comments from the Chairman
NEMA ei June 2017 - Views
NEMA ei June 2017 - Electric News
NEMA ei June 2017 - Looking Ahead for Building Systems
NEMA ei June 2017 - Adding Value through ESPCs
NEMA ei June 2017 - Energy Benchmarking Equals Energy Savings
NEMA ei June 2017 - 9
NEMA ei June 2017 - Case Studies: NEMA Members Go Big on Innovation
NEMA ei June 2017 - 11
NEMA ei June 2017 - 12
NEMA ei June 2017 - 13
NEMA ei June 2017 - 14
NEMA ei June 2017 - 15
NEMA ei June 2017 - 16
NEMA ei June 2017 - 17
NEMA ei June 2017 - Shining a Light on PV Wire
NEMA ei June 2017 - 19
NEMA ei June 2017 - Advocacy
NEMA ei June 2017 - Code & Standards
NEMA ei June 2017 - 22
NEMA ei June 2017 - International
NEMA ei June 2017 - Business Analytics
NEMA ei June 2017 - Spotlight
NEMA ei June 2017 - Cover4
https://www.nxtbook.com/ygsreprints/NEMA/g78283_nema_july2017
https://www.nxtbook.com/ygsreprints/NEMA/g77252_nema_june2017
https://www.nxtbook.com/ygsreprints/NEMA/g75897_nema_may2017
https://www.nxtbook.com/ygsreprints/NEMA/g74413_nema_april2017
https://www.nxtbook.com/ygsreprints/NEMA/g73647_nema_march2017
https://www.nxtbook.com/ygsreprints/NEMA/g72371_nema_february2017
https://www.nxtbook.com/ygsreprints/NEMA/g71716_nema_january2017
https://www.nxtbook.com/ygsreprints/NEMA/g70286_nema_december16
https://www.nxtbook.com/ygsreprints/NEMA/g68064_nema_november16
https://www.nxtbook.com/ygsreprints/NEMA/g67417_nema_october16
https://www.nxtbook.com/ygsreprints/NEMA/g65247_nema_september16
https://www.nxtbook.com/ygsreprints/NEMA/g64195_nema_august16
https://www.nxtbook.com/ygsreprints/NEMA/g62957_nema_july16
https://www.nxtbook.com/ygsreprints/NEMA/g62621_nema_june16
https://www.nxtbook.com/ygsreprints/NEMA/g61522_nema_may16
https://www.nxtbook.com/ygsreprints/NEMA/g60076_nema_apr16
https://www.nxtbook.com/ygsreprints/NEMA/g59228_nema_mar16
https://www.nxtbook.com/ygsreprints/NEMA/Nema_feb16
https://www.nxtbook.com/ygsreprints/NEMA/g56839_nema_jan16
https://www.nxtbook.com/ygsreprints/NEMA/g56034_nema_dec15
https://www.nxtbook.com/ygsreprints/NEMA/g54875_nema_nov15
https://www.nxtbook.com/ygsreprints/NEMA/g54656_nema_oct15
https://www.nxtbook.com/ygsreprints/NEMA/g53383_nema_ei_sept15
https://www.nxtbook.com/ygsreprints/NEMA/ei_aug2015
https://www.nxtbook.com/ygsreprints/NEMA/g51911
https://www.nxtbook.com/ygsreprints/NEMA/G51101_nema_ei_june2015
https://www.nxtbook.com/ygsreprints/NEMA/g50122_nema_ei_may2015
https://www.nxtbook.com/ygsreprints/NEMA/g49416_nema_ei_april2015
https://www.nxtbook.com/ygsreprints/NEMA/g48729_nema_ei_march2015
https://www.nxtbook.com/ygsreprints/NEMA/g47992_nema_ei_feb2015
https://www.nxtbook.com/ygsreprints/NEMA/g47420_nema_jan2015
https://www.nxtbook.com/ygsreprints/NEMA/g46789_nema_ei_dec2014
https://www.nxtbook.com/ygsreprints/NEMA/g45735_nema_nov14
https://www.nxtbook.com/ygsreprints/NEMA/g44837_nema_ei_October2014
https://www.nxtbook.com/ygsreprints/NEMA/g4438_nema_sept2014
https://www.nxtbook.com/ygsreprints/NEMA/g43520_nema_aug14
https://www.nxtbook.com/ygsreprints/NEMA/G42960_nema_ei_july14
https://www.nxtbook.com/ygsreprints/NEMA/g42238_nema_ei_june14
https://www.nxtbook.com/ygsreprints/NEMA/g41547_nema_ei_May14
https://www.nxtbook.com/ygsreprints/NEMA/g40829_nema_ei_apr14
https://www.nxtbook.com/ygsreprints/NEMA/g40178_nema_ei_Mar14
https://www.nxtbook.com/ygsreprints/NEMA/g309513_nema_ei_feb14
https://www.nxtbook.com/ygsreprints/NEMA/g39026_nema_ei_jan14
https://www.nxtbook.com/ygsreprints/NEMA/g38680_nema_ei_dec13
https://www.nxtbook.com/ygsreprints/NEMA/G37864_nema_ei_nov13
https://www.nxtbook.com/ygsreprints/NEMA/G36899_nema_ei_oct13
https://www.nxtbook.com/ygsreprints/NEMA/g36301_nema_ei_sept13
https://www.nxtbook.com/ygsreprints/NEMA/G35638_NEMA_ei_aug13
https://www.nxtbook.com/ygsreprints/NEMA/G35075_NEMA_ei_jul13
https://www.nxtbook.com/ygsreprints/NEMA/g34530_nema_ei_June13
https://www.nxtbook.com/ygsreprints/NEMA/g33413_nema_ei_may13
https://www.nxtbook.com/ygsreprints/NEMA/g32528_nema_ei_march13
https://www.nxtbook.com/ygsreprints/NEMA/g31850_nema_ei_feb13
https://www.nxtbook.com/ygsreprints/NEMA/g31330_nema_ei_Jan13
https://www.nxtbook.com/ygsreprints/NEMA/g30890_nema_ei_dec12
https://www.nxtbook.com/ygsreprints/NEMA/g29979_nema_ei_nov12
https://www.nxtbook.com/ygsreprints/NEMA/g29308_nema_ei_oct12
https://www.nxtbook.com/ygsreprints/NEMA/g28512_nema_ei_sept12
https://www.nxtbook.com/ygsreprints/NEMA/g27967_nema_aug12
https://www.nxtbook.com/ygsreprints/NEMA/g27429_nema_ei_july2012
https://www.nxtbook.com/ygsreprints/NEMA/g26904_nema_eijune2012
https://www.nxtbook.com/ygsreprints/NEMA/g25763_nema_ei_may12
https://www.nxtbook.com/ygsreprints/NEMA/g24906_nema_ei_april12
https://www.nxtbook.com/ygsreprints/NEMA/g24391_nema_ei_mar12
https://www.nxtbook.com/ygsreprints/NEMA/g24069_nema_ei_feb12
https://www.nxtbook.com/ygsreprints/NEMA/g23809_nema_ei_jan12
https://www.nxtbook.com/ygsreprints/NEMA/g23198_nema_ei_dec11
https://www.nxtbook.com/ygsreprints/NEMA/G22670_nema_ei_nov11
https://www.nxtbook.com/ygsreprints/NEMA/g22157_nema_ei_oct11
https://www.nxtbook.com/ygsreprints/NEMA/g21520_nema_ei_sept11
https://www.nxtbook.com/ygsreprints/NEMA/g21115_nema_ei_aug11
https://www.nxtbook.com/ygsreprints/NEMA/g20729_nema_ei_july11
https://www.nxtbook.com/ygsreprints/NEMA/g19430_nema_ei_may11
https://www.nxtbook.com/ygsreprints/NEMA/g19141_nema_ei_april11
https://www.nxtbook.com/ygsreprints/NEMA/g18610_nema_ei_march11
https://www.nxtbook.com/ygsreprints/NEMA/g18431_nema_ei_feb11
https://www.nxtbook.com/ygsreprints/NEMA/g17897_nema_ei_jan11
https://www.nxtbook.com/ygsreprints/NEMA/g17260_nema_ei_dec10
https://www.nxtbook.com/ygsreprints/NEMA/g17025_nema_ei_nov10
https://www.nxtbook.com/ygsreprints/NEMA/g16338_nema_ei_oct10
https://www.nxtbook.com/ygsreprints/NEMA/g15947_nema_ei_sept10
https://www.nxtbook.com/ygsreprints/NEMA/g15556_nema_ei_aug10
https://www.nxtbookmedia.com